UNCY 8-K 2026-08-12

Unicycive Therapeutics, Inc. (UNCY) 8-K dated 2026-08-12 — accession 0001213900-26-088061. This URL is the filing, not the UNCY hub.

Unicycive Therapeutics, Inc. (UNCY) is a biotechnology company listed on NASDAQ.

Unicycive Therapeutics, Inc. filed a 8-K on 2026-08-12. Accession 0001213900-26-088061.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported UNCY revenue for 2023-09-30 was $675.0K. Net income was -$4.3M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. UNCY currently screens at market cap $195.0M.

Not investment advice. The UNCY SEC hub lists recent forms. The stock page is the research view.